SUSHANT BANDARPALLE: Open Payments
NPI 1487073839 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,430 in 46 payments from 7 companies in 2025. Trend: 2023 $884 · 2024 $1,488 · 2025 $1,430
Food & beverage: $1,430
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 21 | $749 |
| ViiV Healthcare Company | 9 | $289 |
| EMD Serono, Inc. | 11 | $261 |
| ABBVIE INC. | 2 | $55 |
| Theratechnologies Inc. | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $20 |
Products named: APRETUDE, Serostim, Yeztugo, MAVYRET, Biktarvy, CABENUVA, EGRIFTA, SHINGRIX.
Industry payments across CA — which companies pay providers there.
